Background illustration for clinical trials search

Paid Clinical Trials Montreal

Discover 1,170 paid clinical trials in Montreal, Quebec. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)

for
Locally Advanced Cervical Cancer
Location: Montreal, Toronto, Hamilton
Sponsor: AstraZeneca

Sex: Female

Age: 15+

Code: NCT06079671

Phase3, Recruiting

Treatment of Brain AVMs (TOBAS) Study

for
Unruptured Brain Arteriovenous Malformation,
Location: Montreal, Boston MA, Jacksonville FL, Edmonton,
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 5+

Code: NCT02098252

Recruiting

Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function

for
Heart Failure and Impaired Kidney Function
Location: Montreal, Greenfield Park, Trois-Rivieres,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT06307652

Phase3, Recruiting

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

for
Breast Cancer
Location: Montreal, Greenfield Park, Quebec, Providence RI,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06103864

Phase3, Recruiting

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

for
Viral Lung Infection and Acute Respiratory Failure
Location: Montreal, Ottawa, Quebec, Levis, Toronto, Brampton,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT05624450

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

for
Chronic Kidney Disease and Hypertension
Location: Montreal, Laval, Burlington VT, Quebec, Albany NY,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06742723

Phase3, Recruiting

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

for
Endometrial Cancer
Location: Montreal, Lebanon NH, Quebec, Boston MA, Providence RI,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT06989112

Phase3, Recruiting

Using Micro-filaments to Detect "fast Ripples" and Improve the Identification of the Epileptogenic Zone

for
Epilepsy, Refractory
Location: Montreal
Sponsor: Adrien Peyrache

Sex: All

Age: 0+

Code: NCT05254730

Recruiting

Analysis of a Biomarker Signature in Patients With Multiple Sclerosis (MS) Treated With Gilenya (FTY720)

for
Multiple Sclerosis
Location: Montreal
Sponsor: McGill University

Sex: All

Age: 18 - 65

Code: NCT02408380

Recruiting
New

External Beam and Radioligand Radiotherapy for mCRPC

for
Prostate Cancer Metastatic Castration-Resistant
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: Male

Age: 0+

Code: NCT07354594

Phase2, Recruiting
New

Pulse Radiotherapy to Overcome Metastatic Immune System Evasion in Lung Cancer

for
Non Small Cell Lung Cancer, Metastatic Lung Cancer
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT06622174

Phase1, Recruiting
New

Lesion Size Measurement During Gastrointestinal Endoscopies

for
Polyp of Colon, Crohn Disease
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT07770425

Recruiting

A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors

for
Cervical Cancer,
Location: Montreal, Hackensack NJ, Hamilton, Iowa City IA,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT04895709

Phase1, Phase2, Recruiting

Therapeutic Plasma Exchange in Septic Shock: A Pilot Study

for
Septic Shock
Location: Montreal, Ottawa, Quebec, Kingston, Toronto, Hamilton,
Sponsor: University of Manitoba

Sex: All

Age: 16+

Code: NCT05093075

Phase2, Recruiting

Choline-PET: Exploratory Study Assessing the Potential Role of F-choline PET Imaging in New and Emerging Indications

for
Lesion With Known or Suspected F-choline Uptake
Location: Montreal
Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)

Sex: All

Age: 18+

Code: NCT04999215

Phase3, Recruiting

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

for
Non Small Cell Lung Cancer
Location: Montreal, Greenfield Park, Westbrook ME, Ithaca NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06312137

Phase3, Recruiting

Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)

for
DCIS
Location: Montreal, Greenfield Park, Trois-Rivieres, Quebec,
Sponsor: Ontario Clinical Oncology Group (OCOG)

Sex: Female

Age: 46+

Code: NCT04797299

Recruiting

The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)

for
Coronary Artery Disease, Heart Failure Systolic
Location: Montreal, Ottawa, Quebec, New Haven CT, Newmarket,
Sponsor: Sunnybrook Health Sciences Centre

Sex: All

Age: 18+

Code: NCT05427370

Recruiting

Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

for
Solid Tumours
Location: Montreal, New Haven CT, Toronto, New York NY,
Sponsor: Boehringer Ingelheim

Sex: All

Age: 18+

Code: NCT06581432

Phase2, Recruiting

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

for
Epithelial Ovarian Cancer, Primary Peritoneal,
Location: Montreal, Boston MA, New Haven CT, Toronto,
Sponsor: TORL Biotherapeutics, LLC

Sex: Female

Age: 18+

Code: NCT06690775

Phase2, Recruiting